Roche, Daiichi Sankyo Form CDx Alliance

Nov 27, 2018

|

NEW YORK (360Dx) — Japanese drugmaker Daiichi Sankyo announced today that it has partnered with Roche to develop an immunohistochemistry-based companion diagnostic for one of its investigational breast cancer drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Roche, Daiichi Sankyo Form CDx Alliance

To read the full story....

Breaking News

Pro-Lab Diagnostics Nabs FDA Emergency Use Authorization for Molecular SARS-CoV-2 Test

HHS Invests $6.5M in Aegis Sciences, Sonic Healthcare USA to Expand Coronavirus Testing Capacity

Myriad Genetics Q4 Revenues Plummet 57 Percent on Coronavirus Pandemic Pressures

Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO

In Brief This Week: Thermo Fisher Scientific, Quanterix, BGI, Illumina, and More

Aspira Q2 Revenues Down 32 Percent

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

What's Popular?

Paige Expects FDA-Cleared Image Viewer, Future AI Products to Expand Digital Pathology Adoption

Strata, Mirati Therapeutics Partner on Tumor-Agnostic Clinical Trial of Novel KRAS G12C Inhibitor

Aspira Q2 Revenues Down 32 Percent

RenalytixAI, Academic Partners to Monitor Chronic Kidney Disease in Recovered COVID-19 Patients

International Group Developing Point-of-Care Flow Cytometer for One-Day Diagnosis of Breast Cancer

Sponsorships